News

Through poetry, explore the inspiring journey of Dr Benjamin Griffeth, a retired Navy veteran, as his colleague Dr Frank Clark reflects on his impactful legacy.

Psychiatrists navigate the complexities of mental health care, balancing evidence-based practices with patient-centered approaches amidst social media scrutiny.

The FDA has approved the Leqembi subcutaneous autoinjector for at-home Alzheimer disease treatment.

Check out the pipeline updates from August!

A new mobile app has been found to reduce suicidal behavior post hospitalization in patients at high suicide risk.

Explore Joe Pierre, MD's insightful analysis of why we believe falsehoods, blending psychology and cognitive science to address misinformation's impact on society.

Explore the psychological interplay of love and aggression in wartime, as Freud's theories resonate with today's conflicts and relationships.

Trauma can span generations. Let's help break the cycle with these 10 steps.

Care partners for patients with schizophrenia can greatly benefit from psychoeducation provided by clinicians.

Obesity is more than a weight issue--it can be reclassified as an embodied disorder. This reflection explores how shame, bodily self-awareness, and early developmental disruptions shape the lived experience of being overweight

NRX-100, a preservative-free ketamine, is granted expanded access for treatment of suicidal ideation in depression, offering new hope for patients.

Black youth, particularly boys, face mischaracterization and punishment in schools.

A farewell to Max Fink, MD, who passed this June. He was a pioneer in the field of electroconvulsive therapy.

BioXcel Therapeutics reveals promising phase 3 results from the SERENITY trial, paving the way for potential at-home treatment of agitation in bipolar disorder and schizophrenia.

Dive into the forms of assessment for cognitive dysfunction in relation to the diagnosis and treatment of schizophrenia.

Read about opinions and events in firearm injury prevention among adolescents and clinicians.

Warren Brody, MD: Ahead of his time? Remembering his life and legacy.

Read the full, exclusive transcript from the inaugural "Brain Trust: Conversations in Clinical Psychopharmacology" video with Joseph F. Goldberg, MD, and Marlene Freeman, MD.

OpenAI acknowledges ChatGPT's risks to psychiatric patients and commits to improving safety measures, but skepticism about their sincerity remains.

Incannex Healthcare shared positive data from its phase 2 clinical trial of PSX-001, a psilocybin-assisted psychotherapy treatment for generalized anxiety disorder.

Reflect on the risk artificial intelligence poses to psychiatric patients and the ethical questions that arise from this new technology.

In this CME, learn about the convergence of neuroscience and spirituality.

Most of the US population—nearly 80%—endorse spiritual and/or religious beliefs. How can these beliefs be applied to psychiatry?

Leqembi for the treatment of Alzheimer disease has been launched in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025—the first launches in the EU.

Explore Jacques Lacan's revolutionary psychoanalytic theories, including the Imaginary, Symbolic, and Real registers, reshaping our understanding of identity and desire.

It's been 20 years since Hurricane Katrina. What lessons have we learned and what lessons do we still need?

Indigenous communities experience disproportionate rates of trauma, mental illness, poverty, and institutional mistrust.

New research highlights lithium's crucial role in brain health, revealing its potential to combat Alzheimer disease and enhance mental wellness.